title: Neurocysticercosis: treatment with albendazole and dextrochloropheniramine (preliminary report).
authors.forename: S
authors.initials: S
authors.lastname: Agapejev
authors.forename: D A
authors.initials: DA
authors.lastname: Meira
authors.forename: B
authors.initials: B
authors.lastname: Barraviera
authors.forename: J M
authors.initials: JM
authors.lastname: Machado
authors.forename: P C
authors.initials: PC
authors.lastname: Pereira
authors.forename: R P
authors.initials: RP
authors.lastname: Mendes
authors.forename: A
authors.initials: A
authors.lastname: Kamegasawa
authors.forename: P R
authors.initials: PR
authors.lastname: Curi
mesh_terms: D015766:Albendazole; D000871:Anthelmintics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D002744:Chlorpheniramine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003551:Cysticercosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans
chemical_list: D000871:Anthelmintics; D001562:Benzimidazoles; C018904:dexchlorpheniramine; D002744:Chlorpheniramine; D015766:Albendazole